These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18076694)

  • 21. There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy.
    Netterlid E; Hindsén M; Björk J; Ekqvist S; Güner N; Henricson KA; Bruze M
    Contact Dermatitis; 2009 Jan; 60(1):41-9. PubMed ID: 19125720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ; Cowan BJ; Hashimoto SA
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous nodule after vaccination with an aluminum-containing vaccine.
    Avcin S; Jazbec J; Jancar J
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Dec; 17(4):182-4. PubMed ID: 19104744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminium in allergen-specific subcutaneous immunotherapy--a German perspective.
    Kramer MF; Heath MD
    Vaccine; 2014 Jul; 32(33):4140-8. PubMed ID: 24892252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cutaneous sarcoidosis secondary to inhalation of wall insulating material particles].
    Bodokh I; Brun P; Mayaffre C; Majcwrczyk N; Montagne M
    Ann Dermatol Venereol; 1998 Mar; 125(3):182-4. PubMed ID: 9747244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Aluminum hydroxide as the cause of unspecificity in the intracutaneous vaccinia test].
    Ehrengut W
    Dtsch Med Wochenschr; 1972 Jan; 97(1):25. PubMed ID: 5007324
    [No Abstract]   [Full Text] [Related]  

  • 27. Subcutaneous sarcoidosis.
    Vainsencher D; Winkelmann RK
    Arch Dermatol; 1984 Aug; 120(8):1028-31. PubMed ID: 6465908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma.
    Guillard O; Fauconneau B; Pineau A; Marrauld A; Bellocq JP; Chenard MP
    J Trace Elem Med Biol; 2012 Oct; 26(4):291-3. PubMed ID: 22425036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent nodules at injection sites (aluminium granuloma) -- clinicopathological study of 14 cases with a diverse range of histological reaction patterns.
    Chong H; Brady K; Metze D; Calonje E
    Histopathology; 2006 Jan; 48(2):182-8. PubMed ID: 16405667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous sarcoidosis: a predictor of systemic disease?
    Meyer-Gonzalez T; Suarez-Perez JA; Lopez-Navarro N; Hidalgo A; Herrera-Ceballos E
    Eur J Intern Med; 2011 Dec; 22(6):e162-3. PubMed ID: 22075313
    [No Abstract]   [Full Text] [Related]  

  • 32. Subcutaneous sarcoidosis with neurological involvement: an unusual combination.
    Kerner M; Ziv M; Abu-Raya F; Horowitz E; Rozenman D
    Isr Med Assoc J; 2008 Jun; 10(6):428-30. PubMed ID: 18669139
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Specific desensitization with inhalation antigens].
    Fuchs E
    Dtsch Med Wochenschr; 1966 May; 91(19):904-6. PubMed ID: 5910731
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessing the safety of subcutaneous immunotherapy dose adjustments.
    Webber CM; Calabria CW
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):369-75. PubMed ID: 21055663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scar sarcoidosis after hyaluronic acid injection.
    Dal Sacco D; Cozzani E; Parodi A; Rebora A
    Int J Dermatol; 2005 May; 44(5):411-2. PubMed ID: 15869540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcoidosis.
    Kim C; Long WT
    Dermatol Online J; 2004 Nov; 10(3):24. PubMed ID: 15748594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous sarcoidosis: report of two cases and review of the literature.
    Dalle Vedove C; Colato C; Girolomoni G
    Clin Rheumatol; 2011 Aug; 30(8):1123-8. PubMed ID: 21461650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subcutaneous sarcoidosis as the first manifestation of systemic disease].
    Calzado L; Galera CM; Arrue I; Rodríguez-Peralto JL; López S; Guerra A; Vanaclocha F
    Actas Dermosifiliogr; 2005; 96(6):379-81. PubMed ID: 16476258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical management and outcome of scalp subcutaneous granuloma annulare in children: case report.
    Jankowski PP; Krishna PH; Rutledge JC; Waldhausen J; Avellino AM
    Neurosurgery; 2008 Nov; 63(5):E1002; discussion E1002. PubMed ID: 19005364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.